A subscription to JoVE is required to view this content. Sign in or start your free trial.
A novel method for 3D scanning and virtual mapping of cancer resections is proposed with the goal of improving communication among the multidisciplinary cancer care team.
After oncologic resection of malignant tumors, specimens are sent to pathology for processing to determine the surgical margin status. These results are communicated in the form of a written pathology report. The current standard-of-care pathology report provides a written description of the specimen and the sites of margin sampling without any visual representation of the resected tissue. The specimen itself is typically destroyed during sectioning and analysis. This often leads to challenging communication between pathologists and surgeons when the final pathology report is confirmed. Furthermore, surgeons and pathologists are the only members of the multidisciplinary cancer care team to visualize the resected cancer specimen. We have developed a 3D scanning and specimen mapping protocol to address this unmet need. Computer-aided design (CAD) software is used to annotate the virtual specimen clearly showing sites of inking and margin sampling. This map can be utilized by various members of the multidisciplinary cancer care team.
The goal of oncologic resection is the complete removal of cancer with surgical margins microscopically clear of tumor cells. In head and neck cancer, the surgical margin status is the most important pathologic risk factor1. A positive surgical margin increases the risk of 5-year local recurrence and all-cause mortality by >90%2. Despite advances in medical technology and surgical techniques in recent years, positive margin rates in head and neck cancer remain high3. For locally advanced oral cavity cancers, the positive margin rate within the United States is 18.1%4.
For head and neck surgeons to ensure complete oncologic resection while minimizing disruption of surrounding structures, intraoperative sampling of margins via frozen section analysis (FSA) is performed. FSA provides a rapid intraoperative pathology consultation that is widely used and is the standard of care5,6,7,8,9. Fresh tissue is frozen, thinly sliced, placed on a glass slide, and stained for immediate interpretation while the patient is still under anesthesia.
Head and neck oncologic specimens present several distinct challenges in accurately assessing margin status, including the anatomic complexity of head and neck cancer specimens, the minimal reserve in the head and neck region for wide excision given the proximity to vital structures such as the eyes, face, and important nerves and vasculature, and the multiple tissue types often present in the resected specimen (i.e., mucosa, cartilage, muscle, bone)10,11. Thus, a specimen-based approach to margin analysis requires an enhanced level of communication between surgeon and pathologist12. A face-to-face conversation is often warranted to ensure correct specimen orientation and discussion of concerning margins. However, this is not always safe or feasible as it requires either the surgeon to leave the operating room (OR) while the patient remains under general anesthesia or the pathologist to leave the gross pathology lab, interrupting their workflow. In addition, there may be a significant travel time between the OR and the pathology lab, or in some cases, the pathology lab may be off-site altogether.
Following FSA, the oncologic specimen is fixed in formalin and formally processed through inking, sectioning, and margin sampling. Slides are created and microscopically interpreted by the pathologist to create a final pathology report. For complex head and neck cancer resection, this can often take 1-2 weeks. Unfortunately, processing of the specimen commonly results in the destruction of the resected cancer specimen. This may create further confusion as the final pathology report, multidisciplinary tumor board discussions, adjuvant radiation therapy planning, and re-resection in the setting of positive margins, must all proceed without a visual record of the oncologic specimen and its pathologic processing.
To address this clinical unmet need, we have developed a 3D scanning and specimen mapping protocol to enhance communication between surgeons, pathologists, and other members of the multidisciplinary cancer care team.
This protocol was performed at Vanderbilt University Medical Center under IRB#221597. Patients provided written consent for ex vivo 3D scanning and digital mapping of their surgical specimen prior to surgery and the addition of their scan to a 3D specimen model biorepository. Inclusion criteria were patients 18 and older with a suspected or biopsy-proven head and neck neoplasm undergoing surgical resection. 3D specimen maps were created based on surgeon and pathologist preference and staff availability.
This protocol follows the guidelines of the human research ethics committees of the Institutional Review Board (IRB#221597) at Vanderbilt University Medical Center. All subjects provided written informed consent prior to participation. All patient data have been de-identified.
1. Setting up the 3D scanner
2. Specimen handling
3. 3D scanning following en bloc resection of solid tumor
4. Alignment and meshing
5. Cleanup
6. Virtual 3D specimen mapping
7. Creating a distributable video
From October 2021 to April 2023, 28 head and neck oncologic specimens were 3D scanned and virtually mapped according to this protocol. These results were previously published13. The majority of the surgical specimens were squamous cell carcinoma (SCC) (86%, n = 24), with the most common anatomic subsites being oral cavity (54%, n = 15) and larynx (29%, n = 8).
In all cases, specimen maps were shared with attending surgeons and pathologists prior to the evaluation of the...
Traditionally, there is no visual representation of a resected cancer specimen. Pathologic processing often destroys the specimen. Prior work has demonstrated the feasibility and utility of 3D scanning of oncologic specimens followed by virtual annotation of the models to create 3D specimen maps which are representative of pathologic processing13,14,15. This provides the multidisciplinary care team with a visual model of the ana...
The authors have no competing financial interests to be disclosed.
This work was supported by a Vanderbilt Clinical Oncology Research Career Development Program (K12 NCI 2K12CA090625-22A1), the NIH/National Institute for Deafness and Communication Disorders (R25 DC020728), Vanderbilt-Ingram Cancer Center Support Grant (P30CA068485) and Swim Across America.
Name | Company | Catalog Number | Comments |
Computer Aided Design Software | MeshMixer | Virtual annotation software for 3D models | |
Digital Camera or Cameraphone | iPhone | May use iPhone camera or any digital camera available | |
EinScan SP V2 Platinum Desktop 3D Scanner | Shining 3D | 3D scanner hardware | |
ExScan Software; Solid Edge SHINING 3D Edition | Shining 3D | 3D capture software included with purchase of 3D Scanner | |
External Mouse | Microsoft | ||
Laptop Computer | Dell XP5 | 00355-60734-40310-AAOEM | Laptop Requirements: USB: 1 ×USB 2.0 or 3.0; OS: Win 7, 8 or 10 (64 bit); Graphic Card: Nvidia series; Graphic memory: >1 G; CPU: Dual-core i5 or higher; Memory: >8 G |
Microsoft Office Suite | Microsoft | ||
Mobile Presentation Cart | Oklahoma Sound | PRC450 | |
PowerPoint Software | Microsoft Office | Presentation software | |
Sit-Stand Mobile Desk Cart | Seville Classics | ||
USB-c Device Converter | TRIPP-LITE | U442-DOCK3-B | Necessary only if laptop does not have USB |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved